Blogopmaak
Annemieke Aartsma-Rus is the elected DCRT chair 2022-2024
Prof. dr. Annemieke Aartsma-Rus was elected as the new chair of the DCRT for the year 2022-2024. Prof. dr. Rob Collin is chosen as the Vice-Chair. Both are very excited to see what the DCRT will accomplish in the coming two years! Annemieke is also involved in the international rare disease research consortium and highlights what they have accomplished in the last 10 years in her #apaperaday on twitter.
published on Feb 3, 2022
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam